Linda L Grasfeder

Title: Linda L Grasfeder: Innovator in Deflazacort Therapy

Introduction

Linda L Grasfeder is a notable inventor based in Durham, NC (US). She has made significant contributions to the field of medicine, particularly in the treatment of Duchenne muscular dystrophy (DMD). Her innovative approach to deflazacort therapy has garnered attention in the medical community.

Latest Patents

Linda holds a patent for "Methods of administering deflazacort therapy." This patent outlines a method of administering a fixed dose of deflazacort to subjects suffering from DMD. The therapy includes increasing the dosage when the subject loses ambulation or adjusting the dosage during the administration of CYP3A inducers or inhibitors. She has 1 patent to her name.

Career Highlights

Linda is currently associated with PTC Therapeutics, Inc., where she continues to work on innovative therapies. Her research focuses on improving treatment outcomes for patients with DMD, showcasing her commitment to advancing medical science.

Collaborations

Linda collaborates with esteemed colleagues, including Scott Joseph Brantley and Virginia D Schmith. Their combined expertise contributes to the development of effective therapies in the field.

Conclusion

Linda L Grasfeder's work in deflazacort therapy represents a significant advancement in the treatment of Duchenne muscular dystrophy. Her innovative methods and dedication to research continue to impact the lives of many patients.